Back to Journals » Stem Cells and Cloning: Advances and Applications » Call For Papers

Stem Cells and Cloning: Advances and Applications

ISSN: 1178-6957


The following Article Collection/ Thematic Series is currently open for submissions:

Tissue Stem Cells

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Tissue Stem Cells" in Stem Cells and Cloning: Advances and Applications.

Tissue stem cells, also known as somatic or adult stem cells, are usually multipotent and can differentiate into a limited number of adult and specialized cell types. They are found in low numbers in adult tissues and are considered as a rare population of cells present throughout the postnatal life. These cells produce mature cell types that facilitate generating the tissue in which they reside. They also maintain tissue homeostasis by replacing cells lost due to continuous tissue turnover or injury. Tissue stem cells can be isolated from wide variety of sources such as bone marrow, umbilical cord and cord blood, adipose tissue, and dental pulp. 

The aim of this Article Collection is to highlight hematopoietic stem cells and mesenchymal stromal cells, which have shown great promise in regenerative medicine and dentistry. These cells have the potential to advance cellular therapeutics for a wide range of diseases. As we can isolate tissue stem cells from a variety of sources, examining the self-renewal and differentiation potential of these stem cells in various tissue types is at the forefront of stem cell research. 

In this Article Collection, we will explore research highlighting the numerous types of tissue stem cells and their translational capacity for regenerative purposes. We welcome original research, reviews, hypothesis formation, technology reviews, and short reports related to the isolation, characterization, and/or functionality of stem cells isolated from (but not limited to):

  • Bone marrow
  • Umbilical cord, cord blood. amniotic fluid, placentae, and Wharton’s jelly
  • Dental pulp and gingival tissue
  • Adipose tissue
  • Skeletal muscle and tendon
  • Perivascular fraction of cells from various tissues

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 30 June 2024.

Please submit your manuscript on our website, quoting the promo code CAAEI to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Mohsin Wahid, Tenure Track Associate Professor of Pathology, Dow University of Health Sciences

[email protected]

View all papers in this article collection


Call For Papers

Editor-in-Chief: Bernard Binetruy, PhD


To see where Stem Cells and Cloning: Advances and Applications is indexed online view the Journal Metrics

What is the advantage to you of publishing in Stem Cells and Cloning: Advances and Applications?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although Stem Cells and Cloning: Advances and Applications receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Stem Cells and Cloning: Advances and Applications has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Stem Cells and Cloning: Advances and Applications  is indexed on PubMed Central (title abbreviation: Stem Cells Cloning). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Dr Bernard Binetruy
Editor-in-Chief
Stem Cells and Cloning: Advances and Applications

Email: Editor-in-Chief